News >

Global HPV Vaccination Reshaping Standard of Care for Cervical Cancer Prevention

Danielle Bucco
Published: Monday, Jan 15, 2018

Xavier Bosch, MD

Xavier Bosch, MD
According to the Centers for Disease Control and Prevention, incidence rates of HPV-associated cancers continue to rise, with approximately 39,000 new HPV-associated cancers now diagnosed annually in the United States.

, Bosch, a senior consultant at the Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Institut Catala d' Oncologia–Catalan Institute of Oncology, discussed a second-generation vaccination against HPV for the prevention of cervical cancer.

OncLive: Can you discuss the HPV vaccination for cervical cancer prevention in Europe?

Bosch: These second-generation vaccines have the ability to protect against 7 HPV types that cause cervical cancer and a number of other cancers in males and females.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication